Second International Conference on Cancer Vaccines/Adjuvants/Delivery for the Next Decade (CVADD): Heidelberg, Germany, 10-12 October 2007

/in , , /von

PMID: 18270701
Journal: Cancer immunology, immunotherapy : CII (volume: 57, issue: 9, Cancer Immunol. Immunother. 2008 Sep;57(9):1421-7)
Published: 2008-02-13

Authors:
Schirrmacher V, Beckhove P, Fournier P, Umansky V

ABSTRACT

Open in PubMed

Das könnte Dich auch interessieren
High cell surface expression of Newcastle disease virus proteins via replicon vectors demonstrates syncytia forming activity of…
Recombinant Newcastle disease virus expressing human interleukin-2 serves as a potential candidate for tumor therapy
Strong T‑cell costimulation can reactivate tumor antigen‑specific T cells in late‑stage metastasized colorectal carcinoma patients: results from…
Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer
Long-term survival of a breast cancer patient with extensive liver metastases upon immune and virotherapy: a case…
Influence of adjuvant hormone therapy and chemotherapy on the immune system analysed in the bone marrow of…